Absci Corporation (ABSI) vs uniQure N.V. (QURE)
- Absci Corporation ABSI 8.25 −7.09%
- uniQure N.V. QURE 21.72 −3.55%
Absci Corporation and uniQure N.V. are both Biotechnology companies. Absci Corporation and uniQure N.V. are of similar size ($1.6B and $1.5B). uniQure N.V. grew revenue faster over the last twelve months: 30.2% against −62.3%. uniQure N.V. has the higher net margin (−1,350.7% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 18 metrics below, uniQure N.V. leads on 10 and Absci Corporation on 8.
Valuation
Profitability
| Metric | ABSI | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.49% | 65.16% |
| Operating margin | (8,084.50%) | (1,071.53%) | 0.00% |
| Net margin | (7,756.37%) | (1,350.73%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (864.67%) | 0.00% |
| Return on equity | (57.72%) | (157.61%) | (56.36%) |
| Return on assets | (50.57%) | (32.13%) | (48.04%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack